SELLAS Life Sciences Group, Inc. (SLS) financial statements (2021 and earlier)

Company profile

Business Address 7 TIMES SQUARE
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments357521830
Cash and cash equivalents357521830
Restricted cash and investments00010180
Receivables     22
Prepaid expense00    
Capitalized contract cost1  
Disposal group, including discontinued operation    10
Other undisclosed current assets010011
Total current assets:3786133754
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment    00
Intangible assets, net (including goodwill)2222066
Goodwill222266
Intangible assets, net (excluding goodwill)   18  
Regulated entity, other noncurrent assets     (0)
Deposits noncurrent assets111100
Deferred tax assets, net  (6)(5)
Other undisclosed noncurrent assets669 2828
Total noncurrent assets:9811202829
TOTAL ASSETS:461717346682
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7561557
Accounts payable5441212
Accrued liabilities212345
Deferred revenue6 
Debt 0 8165
Estimated litigation liability   1125
Disposal group, including discontinued operation    66
Other undisclosed current liabilities0   215
Total current liabilities:1256253057
Noncurrent Liabilities
Long-term debt and lease obligation1  3  
Long-term debt, excluding current maturities   3  
Operating lease, liability1 
Liabilities, other than long-term debt00 2  
Deferred tax liabilities, net 2  
Deferred income tax liabilities00
Other undisclosed noncurrent liabilities5563712
Total noncurrent liabilities:6567712
Total liabilities:181112313769
Stockholders' equity
Stockholders' equity attributable to parent, including:286522914
Common stock000000
Treasury stock, value    (4)(4)
Additional paid in capital1461078756335297
Accumulated deficit(118)(101)(82)(54)  
Other undisclosed stockholders' equity attributable to parent    (303)(279)
Total stockholders' equity:286522914
TOTAL LIABILITIES AND EQUITY:461717346682

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2     
Cost of revenue (20)(31)(5)  
Cost of goods and services sold   (5)  
Gross profit:2(20)(31)(5)  
Operating expenses(19)  (23)(32)(34)
Other undisclosed operating income   5  
Operating loss:(17)(20)(31)(23)(32)(34)
Nonoperating income (expense)0(19)(29) 21(4)
Other nonoperating income0   51
Interest and debt expense  1 3 
Other undisclosed loss from continuing operations before equity method investments, income taxes    (3) 
Loss from continuing operations before equity method investments, income taxes:(17)(39)(59)(23)(11)(39)
Other undisclosed income (loss) from continuing operations before income taxes 2030(0)  
Loss from continuing operations before income taxes:(17)(19)(29)(24)(11)(39)
Income tax expense (benefit)001(0)(0)(0)
Other undisclosed loss from continuing operations (0)    
Net loss:(17)(19)(28)(24)(11)(39)
Other undisclosed net loss attributable to parent    (12)(25)
Net loss attributable to parent:(17)(19)(28)(24)(24)(64)
Preferred stock dividends and other adjustments  (4)   
Other undisclosed net loss available to common stockholders, basic(0)(9)(9)(1)  
Net loss available to common stockholders, diluted:(17)(28)(41)(24)(24)(64)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(17)(19)(28)(24)(11)(39)
Other comprehensive loss     (64)
Comprehensive loss, net of tax, attributable to parent:(17)(19)(28)(24)(11)(103)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: